Abdel‐Baset Halim
Impact in
- Hepatology top 10%
- Hepatitis C virus research
- Internal Medicine top 10%
Papers in
- Surgery 4
- Bladder and Urothelial Cancer Treatments 2
- Pancreatic function and diabetes 1
-
- Genetics, Bioinformatics, and Biomedical Research 1
- Co-authors
- O. El-Ahmady (5 shared papers)Arthur M. Geller (2 shared papers)Leighton LeGros (1 shared paper)Malak Kotb (1 shared paper)Naoki Hiramatsu (1 shared paper)Michael A. Gerber (1 shared paper)S. Dash (1 shared paper)M Samama (1 shared paper)
- Journals
- The International Journal of Biological Markers (2 papers)Biomarkers in Medicine (2 papers)Cancer (1 paper)Clinical Cancer Research (1 paper)Investigational New Drugs (1 paper)
- Partner nations
- United StatesGermanyEgypt
In The Last Decade
Abdel‐Baset Halim
19 papers receiving 530 citations
Peers
Comparison fields: 5 of 79
- Hepatology 100
- Internal Medicine 36
- Pharmacology 71
- Oncology 117
- Rheumatology 54
Countries citing papers authored by Abdel‐Baset Halim
This map shows the geographic impact of Abdel‐Baset Halim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abdel‐Baset Halim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abdel‐Baset Halim more than expected).
Fields of papers citing papers by Abdel‐Baset Halim
This network shows the impact of papers produced by Abdel‐Baset Halim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abdel‐Baset Halim. The network helps show where Abdel‐Baset Halim may publish in the future.
Co-authors
The 25 scholars most cited alongside Abdel‐Baset Halim, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1997 | 109 | |
| 2 | 1999 | 82 | |
| 3 | 2013 | 74 | |
| 4 | Transfection of HepG2 cells with infectious hepatitis C virus genome. | 1997 | 67 |
| 5 | 2012 | 60 | |
| 6 | 2013 | 39 | |
| 7 | 2014 | 36 | |
| 8 | 2014 | 21 | |
| 9 | 2004 | 19 | |
| 10 | The clinical value of CYFRA21-1 in bladder cancer patients: Egyptian experience. | 1999 | 10 |
| 11 | 1994 | 6 | |
| 12 | 1992 | 6 | |
| 13 | 2009 | 6 | |
| 14 | 2001 | 5 | |
| 15 | 2013 | 5 | |
| 16 | 1993 | 5 | |
| 17 | 2011 | 3 | |
| 18 | 2013 | 2 | |
| 19 | 2012 | 2 |
About Abdel‐Baset Halim
Abdel‐Baset Halim is a scholar working on Surgery, Molecular Biology, Oncology, Epidemiology and Physiology, having authored 19 papers that have together received 557 indexed citations. Recurring topics across this work include Clinical Laboratory Practices and Quality Control (3 papers), Meta-analysis and systematic reviews (3 papers), Atrial Fibrillation Management and Outcomes (2 papers), Cancer, Lipids, and Metabolism (2 papers), Health and Medical Research Impacts (2 papers), Bladder and Urothelial Cancer Treatments (2 papers), Pancreatic function and diabetes (1 paper) and Genetics, Bioinformatics, and Biomedical Research (1 paper). The work is most often cited by research in Hepatology (100 citations), Internal Medicine (36 citations), Pharmacology (71 citations), Oncology (117 citations) and Rheumatology (54 citations). Abdel‐Baset Halim has collaborated with scholars based in United States, Germany and Egypt. Frequent co-authors include O. El-Ahmady, Arthur M. Geller, Leighton LeGros, Malak Kotb, Naoki Hiramatsu, Michael A. Gerber, S. Dash, M Samama, Jeanne Mendell and Robert A. Beckman. Their work appears in journals such as The International Journal of Biological Markers, Biomarkers in Medicine, Cancer, Clinical Cancer Research and Investigational New Drugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.